Logo
x

Search

Subscribe Now

EC

Insights+: EMA Marketing Authorization of New Drugs in May 2024

Insights+: EMA Marketing Authorization of New Drugs in May 2024

  • June 20, 2024
The EC Opens Antitrust Investigation Against Vifor Pharma’s Anti-Competitive Disparagement for Iron Deficiency Treatment

The EC Opens Antitrust Investigation Against Vifor Pharma’s Anti-Competitive Disparagement for Iron Deficiency Treatment

  • June 21, 2022
GSK's Nucala (mepolizumab) Receives the EC's Approval for the Treatment of Eosinophil-Driven Diseases

GSK's Nucala (mepolizumab) Receives the EC's Approval for the Treatment of Eosinophil-Driven Diseases

  • November 18, 2021
Insights+: The US FDA New Drug Approvals in October 2021

Insights+: The US FDA New Drug Approvals in October 2021

  • November 18, 2021
Biogen's Vumerity (diroximel fumarate) Receives the EC's Approval for the Treatment of Relapsing-Remitting Multiple Sclerosis

Biogen's Vumerity (diroximel fumarate) Receives the EC's Approval for the Treatment of Relapsing-Remitting Multiple Sclerosis

  • November 17, 2021
AstraZeneca and Moderna Present Results of AZD8601 in P-IIa EPICCURE Trial for the Treatment of Heart Failure at AHA 2021

AstraZeneca and Moderna Present Results of AZD8601 in P-IIa EPICCURE Trial for the Treatment of Heart Failure at AHA 2021

  • November 16, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.